Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | Phase III trial: chemotherapy plus local-regional radiotherapy in pmNPCC

Ming-Yuan Chen • 1 Oct 2019
ESMO 2019
Head and Neck Cancer

Ming-Yuan Chen, MD, PhD, Sun Yat-Sen University Cancer Center, Guangzhou, China, outlines the key findings from the Phase III trial regarding chemotherapy plus local-regional radiotherapy versus chemotherapy alone in primary metastatic nasopharyngeal carcinoma (NPC). This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

More from Ming-Yuan Chen

1:02
NPC communication between the West and China
Ming-Yuan Chen • 1 Oct 2019

Related Videos

1:03
Challenges in implementing liquid biopsies for head and neck cancer
Mouadh Barbirou • 7 Apr 2024
2:43
Molecular profiling of tumor biomarkers in head and neck cancer
Mouadh Barbirou • 7 Apr 2024
1:40
The future of squamous cell carcinoma research at ESMO Asia 2023
Brian Henick • 6 Dec 2023
0:54
The role of immunotherapy in PD-L1 low advanced squamous cell carcinoma
Brian Henick • 6 Dec 2023
The content of VJOncology is intended for healthcare professionals